Formulation Development
PCI Pharma Services Invests Over $365 Million in EU, US Facilities for Clinical & Commercial Supply of Advanced Drug Delivery & Drug-Device Combination Products
PCI Pharma Services is investing more than $365 million in infrastructure supporting the clinical and commercial-scale final assembly and packaging of drug-device combination products utilizing advanced…
Lonza & Vertex Sign a Long-Term Commercial Supply Agreement for CASGEVY
Lonza, a global manufacturing partner to the pharmaceutical, biotech, and nutraceutical markets, recently announced the signature of a long-term commercial supply agreement for CASGEVY (exagamglogene…
Quell Therapeutics Expands Manufacturing Capabilities for CAR-Treg Cell Therapy Pipeline Through Partnership With eXmoor pharma
Quell Therapeutics Ltd and eXmoor pharma recently announced a strategic partnership for the manufacture of multiple autologous engineered CAR-Treg cell therapies in Quell’s pipeline targeting autoimmune…
KSQ Therapeutics Announces FDA Clearance of IND Application for a CRISPR/Cas9 Engineered Tumor-Infiltrating Lymphocyte Therapy
KSQ Therapeutics, Inc., in collaboration with The University of Texas MD Anderson Cancer Center (MD Anderson) and the Cell Therapy Manufacturing Center (CTMC), recently announced…
Araris Biotech AG Expands IP Portfolio With Acquisition of Innate Pharma’s Portfolio
Araris Biotech AG recently announced it has entered into an agreement with Innate Pharma. Under the agreement, Innate will assign its portfolio of patents related…
Barinthus Bio Initiates Phase 1 Clinical Trial of for the Treatment of Celiac Disease
Barinthus Biotherapeutics plc recently announced the initiation of its first-in-human Phase 1 trial of VTP-1000 in adults with celiac disease. The randomized, placebo-controlled clinical trial,…
Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of LP-310 for Oral Lichen Planus
Lipella Pharmaceuticals Inc. recently announced an update on its ongoing multi-center Phase 2a clinical trial evaluating LP-310 for the treatment of Oral Lichen Planus (OLP).…
WEBINAR ON DEMAND: Advantages of Carbopol® Polymers in Oral Formulations
In this video, the Lubrizol team together with the IMCD US team takes you through formulation aspects of Carbopol® polymers as well as the results of a case study on an Acetaminophen oral suspension formulation.
WEBINAR - ABISOL Emulsion Preconcentrate Kit & ABISORB-DC Excipient System for Tableting Lipids
ABITEC Technical Business Director, John Tillotson, RPh, PhD, discusses ABITEC’s latest products: The ABISOL Emulsion Preconcentrate kit for the easy formulation of emulsified drug delivery systems and the….
European Microbiome Innovation for Health & Microbiome Therapeutics Innovation Group Announce New Collaboration
The European Microbiome Innovation for Health (EMIH) association recently announced an agreement between the Microbiome Therapeutics Innovation Group (MTIG) and EMIH for a collaboration to advance…
Assembly Biosciences Reports Positive Interim Phase 1a Results From Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate
Assembly Biosciences, Inc. recently announced positive interim pharmacokinetic (PK) and safety results from healthy participants in the Phase 1a portion of its ongoing Phase 1a/b…
Ventyx Biosciences Announces $27-Million Strategic Investment From Sanofi
Ventyx Biosciences, Inc. recently announced Sanofi has agreed to make a $27-million strategic investment in the company at an as-converted price of $3.8243 per share…
Hovione & iBET Announce the Establishment of a Venture in Cell & Gene Therapy Solutions
Hovione and iBET recently announced the official establishment of ViSync Technologies as a jointly owned venture. The creation of this new company, headquartered in the…
Lonza Launches Innovaform Accelerator, the New Innovation & Formulation Center in Colmar (FR)
Lonza, a global manufacturing partner to the pharmaceutical, biotech, and nutraceutical markets, recently inaugurated its new facility at the Colmar (FR) site. The new Innovaform…
Tiziana Life Sciences Announces $4-Million Grant to Study Anti-CD3 in Alzheimer’s Disease
Tiziana Life Sciences, Ltd. recently announced the National Institutes of Health (NIH), National Institute on Aging have awarded a $4-million grant to Dr. Howard Weiner…
Oncolytics Biotech Reports Favorable Results for BRACELET-1 Breast Cancer Study
Oncolytics Biotech Inc. recently announced positive clinical results from BRACELET-1, its randomized Phase 2 study evaluating pelareorep in patients with HR+/HER2- advanced or metastatic breast cancer.…
PlaqueTec & RxCelerate Collaborate on Early Phase Drug Discovery for Coronary Artery Disease
PlaqueTec and RxCelerate recently announced the successful completion of a collaboration to assess small molecules identified from an initial cheminformatics drug screen in a bespoke…
Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
Certara, Inc. recently shared the results from its collaboration with Ichnos Glenmark Innovation (IGI) on the first-in-human dose prediction and selection for ISB 2001. IGI’s…
Sonnet BioTherapeutics Completes Enrollment in Phase 1 Study of SON-1010 (IL12-FHAB) as a Monotherapy (SB101) for the Treatment of Solid Tumors
Sonnet BioTherapeutics Holdings, Inc. recently announced the completion of enrollment and initiation of dosing in its Phase 1 SB101 clinical trial of SON-1010 (IL12-FHAB) in…
Asimov Launches a Suite of AI Models, Host Cells & Genetic Tools for End-to-End Gene Therapy Development
[caption id="attachment_143234" align="alignleft" width="170"] AAV Edge[/caption] Asimov recently announced the launch of the AAV Edge System, a comprehensive suite of tools for adeno-associated viral (AAV)…
